Lidocaine

Generic Name: Lidocaine

Brand Names: Agoneaze, Akten, Alivio, Anestacon, Anodyne Lpt, Astero, Band-aid Hurt-free, Cathejell, Curacaine, Depo-medrol With Lidocaine, Dermacinrx Lido V Pak, Dermacinrx Phn Pak, Dermacinrx Prikaan, Diphen, Emla, Fortacin, Glydo, Instillagel, Kenalog, Lido Bdk, Lido-prilo Caine Pack, Lidocan, Lidodan, Lidoderm, Lidopac, Lidopril, Lidopro, Lidosol, Lidothol, Lidotral, Lignospan, Marcaine, Max-freeze, Medi-derm With Lidocaine, Neo-bex, Octocaine, Octocaine With Epinephrine, Oraqix, P-care, P-care X, Pliaglis, Prilolid, Prizotral, Procomycin, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Relador, Synera, Triple Antibiotic, Venipuncture Px1, Viadur, Xylocaine, Xylocaine With Epinephrine, Xylocard, Xylonor, Zingo, Ztlido

Drug Type: Small Molecule

Chemical Formula: C_₁₄H_₂₂N_₂O

CAS Number: 137-58-6

Unique Ingredient Identifier: 98PI200987

Background: Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication . In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical p...

Indication: Lidocaine is an anesthetic of the amide group indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks .

Associated Conditions: Acute Otitis Media (AOM), Anorectal discomfort, Arrhythmia, Back Pain Lower Back, Bacterial Vaginosis (BV), Burns, Cervical Syndrome, Earache, Fissure;Anal, Haemorrhoids, Infection, Inflammatory Reaction caused by ear infection-not otherwise specified, Insect Bites, Joint Pain, Mixed Vaginal Infections, Multiple Myeloma (MM), Myringitis, Neuritis, Osteolysis caused by Bone Tumors, Osteoporosis, Otitis Externa, Pain caused by ear infection-not otherwise specified, Pain, Inflammatory, Postherpetic Neuralgia, Primary Hyperparathyroidism (PHPT), Rheumatic Diseases, Rheumatic Joint Disease, Sciatica, Skin Irritation, Soft Tissue Inflammation, Sore Throat, Sunburn, Susceptible infections, Trichomonas Vaginitis, Ulcers, Leg, Urethral Strictures, Ventricular Arrhythmia, Vulvovaginal Candidiasis, Abrasions, Anal discomfort, Cutaneous lesions, Gum pain, Minor burns, Superficial Wounds, Susceptible Bacterial Infections, Ulceration of the mouth, Viral infections of the external ear canal

Associated Therapies: Local Anaesthesia therapy, Post Myocardial Infarction Treatment, Regional Anesthesia therapy

Clinical Trials

Lidocaine Injection: A Nove Block Therapy for Stroke-related Dysphagia

Not Applicable

Completed

Conditions: Dysphagia

Interventions: Behavioral: Comprehensive rehabilitation
Drug: Lidocaine Hydrochloride
Procedure: Injection

First Posted Date: 2024-03-08

Last Posted Date: 2024-03-25

Lead Sponsor: Muhammad

Target Recruit Count: 65

Registration Number: NCT06301737

Locations: 🇨🇳
Zhen No.1 Hos., Taiwan, China

Investigation of Potential Mechanisms in Stellate Ganglion Block in Individuals With Cerebral Small Vessel Disease

Not Applicable

Not yet recruiting

Conditions: Cerebral Small Vessel Diseases

Interventions: Behavioral: Rehabilitation therapy
Procedure: Stellate ganglion block
Drug: Lidocaine Hydrochloride

First Posted Date: 2024-03-08

Last Posted Date: 2024-03-12

Lead Sponsor: Ahmadu Bello University Teaching Hospital

Target Recruit Count: 80

Registration Number: NCT06301711

Effectiveness of Stellate Ganglion Block in Individuals With Parkinson's Disease

Not Applicable

Not yet recruiting

Conditions: Parkinson Disease

Interventions: Procedure: Injection
Drug: Lidocaine hydrochloride

First Posted Date: 2024-03-08

Last Posted Date: 2024-03-12

Lead Sponsor: Muhammad

Target Recruit Count: 80

Registration Number: NCT06301724

The Effectiveness of Stellate Ganglion Block in Managing Dysphagia in Patients With Medullary Infarction

Not Applicable

Not yet recruiting

Conditions: Bulbar Palsy

Interventions: Behavioral: Comprehensive rehabilitation
Procedure: Injection
Drug: Lidocaine Hydrochloride

First Posted Date: 2024-03-08

Last Posted Date: 2024-03-12

Lead Sponsor: Ahmadu Bello University Teaching Hospital

Target Recruit Count: 80

Registration Number: NCT06301698

Erector Spinae Plane (ESP) Block vs Intravenous Lignocaine Infusion in (VATS)

Not Applicable

Not yet recruiting

Conditions: Thoracic Surgery, Video-Assisted

Interventions: Procedure: Erector Spinae Plane (ESP) block
Drug: Lignocaine

First Posted Date: 2024-03-04

Last Posted Date: 2024-03-04

Lead Sponsor: Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland

Target Recruit Count: 60

Registration Number: NCT06289790

Locations: 🇵🇱
National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Mazowieckie, Poland

The Effect of Stellate Ganglion Block on Insomnia Patients

Not Applicable

Recruiting

Conditions: Insomnia

Interventions: Procedure: Stellate Ganglion Block
Drug: Lidocaine Hydrochloride

First Posted Date: 2024-02-13

Last Posted Date: 2024-03-12

Lead Sponsor: Zeng Changhao

Target Recruit Count: 50

Registration Number: NCT06255730

Locations: 🇰🇷
Center Rehabilitation Hospital, Seoul, Korea, Republic of

Effect of Stellate Ganglion Block on Pharyngeal Dysphagia After Cerebralvascular Accident

Not Applicable

Completed

Conditions: Dysphagia

Interventions: Behavioral: comprehensive rehabilitation
Drug: Lidocaine hydrochloride

First Posted Date: 2024-02-08

Last Posted Date: 2024-03-12

Lead Sponsor: Zeng Changhao

Target Recruit Count: 65

Registration Number: NCT06249464

Locations: 🇨🇳
Xinzhu Rehabilitation Hospital, Xinzhu, Taiwan

Exploration of Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Not Applicable

Completed

Conditions: Cerebral Small Vessel Diseases

Interventions: Behavioral: Rehabilitation therapy
Procedure: Stellate ganglion block
Drug: Lidocaine Hydrochloride

First Posted Date: 2024-01-26

Last Posted Date: 2024-06-12

Lead Sponsor: Zeng Changhao

Target Recruit Count: 84

Registration Number: NCT06226415

Locations: 🇨🇳
River south medical affili. Campus of zdy, Zhongguo, China
🇨🇳
Affiated Hos. Campus of zdy, Zhongguo, China
🇨🇳
The 4th affili. (Huij) Campus of zdy, Zhongguo, China